Nombre del producto:2-(4-(Dibenzo[b,d]thiophen-4-yl)phenyl)dibenzo[f,h]quinoxaline

IUPAC Name:2-(4-{8-thiatricyclo[7.4.0.0²,⁷]trideca-1(13),2,4,6,9,11-hexaen-6-yl}phenyl)-1,4-diazatriphenylene

CAS:1332748-56-7
Fórmula molecular:C34H20N2S
Pureza:95%
Número de catálogo:CM221243
Peso molecular:488.61

Unidad de embalaje Stock disponible Precio($) Cantidad

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1332748-56-7
Fórmula molecular:C34H20N2S
Punto de fusión:-
Código de sonrisas:C1(C2=CC=C(C3=C4C(C5=CC=CC=C5S4)=CC=C3)C=C2)=NC6=C(C=CC=C7)C7=C(C=CC=C8)C8=C6N=C1
Densidad:
Número de catálogo:CM221243
Peso molecular:488.61
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.